IRIDEX Corporation Total Liabilities
IRIDEX Corporation total liabilities. Based on the latest financial reports, IRIDEX Corporation (IRIX) has total liabilities worth $23.62 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check IRIDEX Corporation (IRIX) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of IRIDEX Corporation (1995–2025)
Total liabilities of IRIDEX Corporation from 1995 to 2025. This chart illustrates how IRIDEX Corporation's total liabilities have evolved over time, based on quarterly financial data.
IRIDEX Corporation Competitors by Total Liabilities
The table below lists competitors of IRIDEX Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Advance Metals Ltd
AU:AVM
|
Australia | AU$1.01 Million |
|
Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
NASDAQ:AHMA
|
USA | $3.58 Million |
|
Silver Ridge Holdings Bhd
KLSE:0129
|
Malaysia | RM57.34 Million |
|
Value8 N.V
AS:PREVA
|
Netherlands | €27.29 Million |
|
Fingerprint Cards AB (publ)
ST:FING-B
|
Sweden | Skr32.20 Million |
|
Microelectronics Technology Inc
TW:2314
|
Taiwan | NT$3.17 Billion |
|
Empire Resources Ltd
AU:ERL
|
Australia | AU$1.56 Million |
|
Western Resources Corp
TO:WRX
|
Canada | CA$127.51 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down IRIDEX Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IRIDEX Corporation (IRIX) total assets.
Liquidity & Leverage Metrics
IRIDEX Corporation Total Liabilities Ratios Explained
IRIDEX Corporation total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.87 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IRIDEX Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IRIDEX Corporation (1995–2025)
The table below shows the annual total liabilities of IRIDEX Corporation from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $24.23 Million | -10.39% |
| 2024-12-31 | $27.04 Million | +8.53% |
| 2023-12-31 | $24.91 Million | -0.58% |
| 2022-12-31 | $25.06 Million | -1.30% |
| 2021-12-31 | $25.39 Million | +139.44% |
| 2020-12-31 | $10.60 Million | -12.43% |
| 2019-12-31 | $12.11 Million | +3.39% |
| 2018-12-31 | $11.71 Million | +5.28% |
| 2017-12-31 | $11.12 Million | +23.82% |
| 2016-12-31 | $8.98 Million | +10.44% |
| 2015-12-31 | $8.13 Million | +0.66% |
| 2014-12-31 | $8.08 Million | +3.31% |
| 2013-12-31 | $7.82 Million | +11.65% |
| 2012-12-31 | $7.01 Million | -27.93% |
| 2011-12-31 | $9.72 Million | -0.71% |
| 2010-12-31 | $9.79 Million | -26.17% |
| 2009-12-31 | $13.27 Million | -19.50% |
| 2008-12-31 | $16.48 Million | -40.82% |
| 2007-12-31 | $27.84 Million | +247.18% |
| 2006-12-31 | $8.02 Million | +21.75% |
| 2005-12-31 | $6.59 Million | -9.89% |
| 2004-12-31 | $7.31 Million | +46.05% |
| 2003-12-31 | $5.00 Million | +22.85% |
| 2002-12-31 | $4.07 Million | +3.01% |
| 2001-12-31 | $3.96 Million | -12.60% |
| 2000-12-31 | $4.53 Million | -12.32% |
| 1999-12-31 | $5.16 Million | +106.44% |
| 1998-12-31 | $2.50 Million | -10.71% |
| 1997-12-31 | $2.80 Million | +27.27% |
| 1996-12-31 | $2.20 Million | +29.41% |
| 1995-12-31 | $1.70 Million | -- |
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more